Global Single-cell Technologies Market Poised for Explosive Growth

PR Newswire
Wednesday, October 9, 2024 at 7:04pm UTC

Global Single-cell Technologies Market Poised for Explosive Growth

PR Newswire

"The Market is growing rapidly, driven by its potential to transform healthcare by enabling personalized treatment and targeted therapies. With increasing investment and innovation, this market is expected to revolutionize the way diseases are diagnosed and treated."

BOSTON, Oct. 9, 2024 /PRNewswire/ -- "According to the latest BCC research study, the demand for Global Single-cell Technologies Market is expected to grow from $3.6 billion in 2023 and is projected to reach $9.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.1% from 2024 through 2029."

BCC Research (PRNewsfoto/BCC Research LLC)

Discover the latest trends and forecasts in the single-cell technologies market with our comprehensive report. Key highlights include:

  • Market projections for 2029 and market share analysis of leading players
  • Detailed market sizing by:
    - Product: Consumables and Instruments
    - Cell Type: Human, Animal, and Microbial Cells
    - Techniques: Flow Cytometry, NGS, PCR, Microscopy, Mass Spectrometry, and more
    - Application: Research and Medical
    - End User: Research Institutions, Biotech and Pharma Companies, Hospitals, Diagnostic Labs, Cell Banks, and IVF Centers

Some Interesting & surprising facts:

Game-Changing Trends in Single-Cell Technologies:

  • AI and Bioinformatics Revolution: Artificial intelligence and bioinformatics advancements are transforming the single-cell technologies market, providing rapid and user-friendly solutions for end-users.
  • Medical Applications on the Rise: The medical application segment is experiencing significant growth, driven by the increasing prevalence of infertility and genetic diseases. Technological advancements are further expanding its application in this field.
  • NGS Segment Boosted by Decreasing Costs: The declining cost of genetic sequencing has fueled the growth of the Next-Generation Sequencing (NGS) segment, making it a leading technology for single-cell analysis.

Get a deeper understanding of the market's dynamics and growth opportunities, click here for further exploration.

Factors contributing to this growth include:

1.  Rising Incidence of Cancer.: The number of people getting cancer is increasing worldwide. This is a worrying trend, and it's happening for several reasons. As the global population grows and people live longer, the risk of cancer goes up. Additionally, unhealthy habits like smoking, poor diet, and lack of exercise contribute to the rise. Environmental factors like pollution and genetic predispositions also play a role. As a result, cancer is becoming a bigger health concern, making it crucial to focus on prevention, early detection, and effective treatments to combat this growing issue.

2.  Growing Demand for Personalized Medicine.: People are increasingly seeking tailored medical treatments that cater to their unique needs and genetic profiles. This demand for personalized medicine is driven by the desire for more effective and targeted care, reduced side effects, and improved health outcomes. With advances in genetic testing and data analysis, individuals can now receive customized treatments that address their specific health conditions, leading to better results and enhanced quality of life. As a result, the demand for personalized medicine is growing, transforming the way healthcare is delivered and revolutionizing the treatment of diseases.

3.  Increasing Investment and Funding.: More and more money is being invested in healthcare research and development, driving innovation and progress in the field. Governments, organizations, and private companies are recognizing the potential for breakthroughs and are putting their resources behind it. This surge in funding is accelerating the discovery of new treatments, technologies, and therapies, bringing hope to patients and families affected by various diseases. As investment grows, so does the potential for life-changing medical advancements, making this an exciting time for healthcare.

Request a Sample Copy of the Global Single-cell Technologies Market

Report Synopsis

Report Metrics

Details

Base year considered

2023

Forecast Period considered

2024-2029

Base year market size

$3.6 billion

Market Size Forecast

$9.2 billion

Growth Rate

CAGR of 17.1% for the forecast period of 2024-2029

Segment Covered

Product, Cell Type, Techniques, Application, End User

Regions covered

North America, Europe, Asia-Pacific, Rest of the World

Countries covered

U.S., Canada, U.K., Germany, France, Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia, Lithunia, Latvia, Hungary, Slovakia, Japan, China, India, Australia, South Korea, Singapore, Malaysia, New Zealand, Thailand, the Philippines, Vietnam, Indonesia, South America, Middle East and Africa

Key Market Drivers

•  Rising Incidence of Cancer

•  Growing Demand for Personalized Medicine

•  Increasing Investment and Funding

 

Market Segmentation

The Global Single-cell Technologies Market can be categorized into various segments:

  • by Product
    The single-cell technologies market is divided into two main product categories: Consumables (such as reagents, kits, and assays) and Instruments (like microscopes, sequencers, and analyzers). Think of it like a lab: consumables are the supplies you use up, while instruments are the equipment you use to get the job done!
  • by Techniques
    The single-cell technologies market uses various techniques to analyze individual cells, including Flow cytometry (sorting cells), Next-generation sequencing (reading genetic code), Polymerase chain reaction (copying DNA), Microscopy (visualizing cells), Mass spectrometry (identifying molecules), and other techniques (like cell isolation and imaging). Think of it like a toolbox - each technique is a unique tool to help scientists understand cells better!
  • by Cell Type
    Cells are the building blocks of life and can be classified into three main types based on their characteristics and functions. Human cells are the cells that make up our bodies, animal cells are found in other living creatures, and microbial cells are tiny cells that are found almost everywhere and include bacteria, viruses, and other microorganisms.
  • by Application
    Cells can be used in various ways, and their applications can be broadly classified into two categories. Research applications involve using cells to gain a deeper understanding of biological processes, test new treatments, and explore the intricacies of life. Medical applications, on the other hand, involve using cells to prevent, diagnose, and treat diseases, such as growing skin for burns, using stem cells to repair damaged tissues, and developing new vaccines.
  • by End User
    Cells are used by various end users for different purposes. These include research and academic laboratories for scientific studies, biotechnology and pharmaceutical companies for developing new treatments, hospitals and diagnostic laboratories for patient care and testing, and cell banks and IVF centers for storing and using cells for reproductive purposes, such as fertility treatments and stem cell storage.

This report on global automated and closed cell therapy market provides comprehensive insights and analysis, addressing the following key questions:

1.  What is the projected market size and growth rate of the single-cell technologies market?

The global single-cell technologies market is expected to grow at a compound annual growth rate (CAGR) of 17.1% to reach $9.2 billion by 2029 from $4.2 billion in 2024.

2.  What are the key factors driving the growth of the single-cell technologies market?

Key drivers of the single-cell technologies market are the rising incidence of cancer, growing demand for personalized medicine, and rising investment and funding.

3.  What segments are covered in the single-cell technologies market?

The single-cell technologies market is segmented based on product, cell type, techniques, application, end user, and region.

4.  By product, which segment will dominate the market by the end of 2029?

The consumables segment will dominate the market by the end of 2029.

5.  Which region has the highest market share in the single-cell technologies market?

North America holds the highest share of the market.

Some of the Key Market Players Are:

•  10X GENOMICS

•  AGILENT TECHNOLOGIES INC.

•  BD         

•  BIO-RAD LABORATORIES INC.

•  DANAHER CORP.             

•  ILLUMINA INC.

•  MERCK KGAA

•  PROMEGA CORP.

•  QIAGEN              

•  THERMO FISHER SCIENTIFIC INC.

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with info@bccresearch.com.

About BCC Research 

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype. 

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library. 

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. 

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/global-single-cell-technologies-market-poised-for-explosive-growth-302272002.html

SOURCE BCC Research LLC